Patent ID: 11858937
Assignee: QURIENT CO., LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 3:
4. The compound according to claim 1, wherein the compound has Formula III:, or a pharmaceutically acceptable salt or stereoisomer thereof,
wherein:
Q is —C(O)—, —C(O)CH2—, —C(O)NH—, —NH—, —NHCH2—, —NHCH2CH2—, —NHC(O)—, —NHS(O)2—, —O—, or —OCH2—;
Ya is absent;
L1 is absent;
Y1 is CH, COH, or N;
Y2 is CH, COH, or N;
R23 is H, halogen, C1-C6 alkyl, C(O)NH2, NR5R5, NHC(O)R5, OR5, heterocyclyl, aryl, or heteroaryl, wherein the C1-C6 alkyl is optionally substituted with one substituent selected from the group consisting of NH2 and OH;
each R24 is independently H, halogen, C1-C6 alkyl, NR5R5, OR5, ═O, heterocyclyl, aryl, or heteroaryl, wherein each C1-C6 alkyl is optionally and independently substituted with one substituent selected from the group consisting of NH2 and OH;
q is 0, 1, or 2; and
r is 0, 1, 2, or 3.